Concepedia

Jennifer Galli

JG

11

Publications

576

Citations

10

H-Index

1994

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

University of Pennsylvania

Jennifer Galli is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in immunology, medicine, and vaccination.

ORCID

Top concepts

Publications per year

1994–2023

11

Publications

11

Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection

Amy S. Espeseth, Pedro J. Cejas, Michael Citron et al. · npj Vaccines · 2020 · 178 citations · Full text

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein

Aimin Tang, Zhifeng Chen, Kara S. Cox et al. · Nature Communications · 2019 · 142 citations · Full text

Protection Provided by a Herpes Simplex Virus 2 (HSV-2) Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1-Seropositive Guinea Pigs

Sita Awasthi, John W. Balliet, Jessica A. Flynn et al. · Journal of Virology · 2013 · 50 citations · Full text

, , +14

Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes

Xiao Xiao, Aimin Tang, Kara S. Cox et al. · mAbs · 2019 · 41 citations · Full text

Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein

Jessica A. Flynn, Eberhard Dürr, Ryan Swoyer et al. · PLoS ONE · 2016 · 36 citations · Full text

, , +17

Rows per page

1–5 of 11